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Background: Previous research has found that exogenous oxytocin administration has the 
potential to modulate attentional biases in women with anorexia nervosa. Recent work has 
indicated that attentional biases to food may reinforce the recurrent binge eating behaviour 
which characterises bulimia nervosa and binge eating disorder. To date, however, no study has 
yet investigated the effect of oxytocin on attentional biases to palatable food in women with 
bulimia nervosa and binge eating disorder.  
Methods: This study employed a single-session crossover design to test the hypothesis that a 
divided dose of 64IU intranasal oxytocin, administered as one intranasal dose of 40IU oxytocin 
followed by a top-up of 24IU oxytocin 80 minutes later, versus placebo administration 
administered in the same dosing schedule, would reduce attentional biases towards food images 
in a dot probe task. We hypothesised that oxytocin administration would reduce vigilance 
towards food to a greater degree in women with bulimia nervosa or binge eating disorder, 
versus healthy comparison women. Twenty-five women with bulimia nervosa or binge eating 
disorder and 27 comparison women without history of an eating disorder were recruited to take 
part in the study.  
Results: Contrary to our hypothesis, there was no main effect of diagnosis on attentional bias 
to food (fixed effect = 5.70, p = .363), nor a significant interaction between diagnosis and drug 
condition (fixed effect = -14.80, p = .645). There was a main effect of drug condition, such that 
oxytocin increased vigilance towards food, versus neutral, images in the dot probe task (fixed 
effect = 10.42, p = .044). A correlation analysis revealed that this effect was moderated by 
attentional bias in the placebo condition, such that greater avoidance of food stimuli in the 
placebo condition was associated with a greater increase in vigilance induced by oxytocin.  
3 
 
Conclusion: The current findings add to a mixed body of literature investigating the 
therapeutic effects of oxytocin in women. Future research would benefit from dose-response 
studies investigating the optimal dose of oxytocin for modulating the attentional processing of 
palatable food in populations with eating disorders. 





Bulimia nervosa (BN) and binge eating disorder (BED) are DSM-5 eating disorders 
characterised by recurrent, loss-of-control binge eating behaviour over a period of at least three 
months (1). Currently, the average remission rate for people with BN and BED remains low 
and treatment presents a significant challenge (2). The development of new treatment 
approaches is therefore warranted to address this unmet need.  
A meta-analysis has found that people with BN exhibit greater vigilance towards food 
words in Stroop tasks when compared to participants without history of an eating disorder (3). 
More recently, evidence has supported the hypothesis that hypervigilance towards food cues is 
associated with core eating disorder behaviours and psychopathology in BN and BED. For 
example, Albery and colleagues (4) used a Stroop task to measure attentional bias to both food- 
and body-related words amongst women with BN. They found that the degree of 
hypervigilance towards food-related words was associated with greater frequency of binge-
purge behaviour. Additionally Svaldi and colleagues (5) used a visual priming task to 
investigate attentional bias to food images, versus neutral images, among obese participants 
with and without BED. While this priming effect ultimately did not differ between the BED 
and non-BED groups of overweight participants, they did find that the degree of priming was 
positively correlated with overall eating disorder psychopathology, as measured using the 
Eating Disorder Examination – Questionnaire (EDE-Q) (6). In a spatial cueing task, Schmitz 
and colleagues (7) also found the same positive correlation between vigilance to food images 
and EDE-Q scores in a sample of participants with BED. 
It has been proposed that attentional bias toward palatable food cues is a cognitive 
maintenance factor for BN and BED, as these preconscious biases enhance the salience of 
external cues for binge eating (8). Evidence suggests that the link between attention to food 
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cues and subsequent binge eating behaviour may be especially strong in these disorders due to 
an automatic stimulus-response association that becomes increasingly reinforced with 
continued binge eating behaviour (9, 10). Previous evidence has indicated that attentional 
biases to food are especially strong following actual food consumption in populations with 
obesity, as compared to healthy control participants (11). However, the effect of food 
consumption on behavioural measures of attentional bias to food has not been investigated in 
people with BN and BED (12). It is therefore of interest to determine whether hypervigilance 
to palatable food occurs prior to food consumption, thus supporting trait levels of heightened 
incentive salience in BN and BED (13), or whether this hypervigilance only or also occurs 
following food consumption, thus potentially highlighting that the onset of food consumption 
triggers subsequent increases in incentive salience. 
Oxytocin is a hormone and neuropeptide commonly known for its roles in modulating 
social perception and behaviour (14). However, in recent years, oxytocin has gained increasing 
attention for its effects on eating in both healthy and clinical populations (15). Recent research 
has suggested that the hormone oxytocin may affect the upstream cognitive and emotional 
processes that contribute to the maintenance of disordered eating behaviour in anorexia 
nervosa. For example, chronic administration of oxytocin has been found to reduce eating 
concern (16) and correct attentional avoidance of food images in women with anorexia nervosa 
(17). This finding potentially carries clinical significance given evidence that attentional 
avoidance of food stimuli is correlated with disorder severity in anorexia nervosa (18), although 
future research is required before causal effects of attentional bias can be determined. Previous 
research has found that exogenous oxytocin administration also reduces vigilance to angry 
faces, an anxiety-provoking social stimulus, in women with BN (19). To our knowledge, 
however, no study has yet investigated the effects of oxytocin on attentional bias to food images 
in BN and BED.  
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It is not entirely clear by what mechanism oxytocin alters attentional bias specifically 
to food images in anorexia nervosa, although the strength of the effect of oxytocin on 
attentional bias is related to the anxiolytic effects of oxytocin with a medium effect size (17). 
It may be the case that anxiety primarily drives baseline attentional biases away from food 
(avoidance) in anorexia nervosa, and the oxytocin-induced reduction in anxiety has the 
downstream effect of normalising this bias. A current lack of evidence does not allow for the 
establishment of firm conclusions regarding the mechanism of the effect oxytocin on 
attentional bias; however, it is reasonable to suspect that oxytocin may exert a similar effect in 
normalising baseline attentional biases towards food (vigilance) in BN and BED if oxytocin 
modulates a common anxiety-based mechanism accounting for baseline attentional biases in 
each disorder, albeit in opposite directions. 
Previous evidence that intranasal oxytocin suppresses hedonic eating in overweight 
men has provided tentative evidence that oxytocin may also suppress the reward salience of 
palatable food (20), which has previously been found to affect preconscious attentional bias 
(21). Furthermore, previous neuroimaging work has found that people recovered from BN 
exhibit similar blood-oxygenated-level-dependent (BOLD) responses within the left putamen, 
a neural region strongly associated with the processing of reward, in response to taste stimuli 
received when either hungry or sated (22). This is in contrast to healthy control participants, 
who exhibit a down-regulated BOLD response in the left putamen following food consumption 
(22). One potential hypothesis stemming from this pattern of effects is that the incentive 
salience of palatable food, and attentional bias to palatable food, will decrease following food 
consumption to a greater degree amongst healthy control participants, as compared to 
participants with BN or BED. Furthermore, previous evidence finding that increased activation 
of oxytocinergic neurons within the paraventricular nucleus of the hypothalamus precedes meal 
termination suggests that the effect of oxytocin in deterring food-seeking, and thus attentional 
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orienting towards food stimuli, may be stronger following food consumption given the role of 
oxytocin in meal termination (23). 
 The current pilot used a double-blind, placebo-controlled crossover design to test the 
effect of a divided dose of 64IU intranasal oxytocin on attentional bias to food images among 
women with BN or BED and comparison women without history of an eating disorder. Our 
hypotheses were: 1) Women with BN or BED would demonstrate greater vigilance towards 
food images than women without history of an eating disorder; 2) Oxytocin administration 
would reduce vigilance towards food images in both groups of women, based on previous work 
suggesting that oxytocin reduces the incentive salience of palatable food in healthy participants 
(24); 3) Oxytocin would reduce vigilance towards food images to a greater degree in women 
with BN or BED, versus healthy comparison women, due to potential flooring effects in the 
healthy comparison group; 4) There would be an interaction between time point and participant 
group, such that the difference in attentional bias to food in the BN/BED, versus healthy control 
group, would be even greater following food consumption. 
Methods 
 Participants 
 Fifty-two women participated in the current study. Given that recurrent binge eating 
behaviour was the primary trait of interest in the current study, and that populations with BN 
and BED are both characterised by recurrent loss-of-control binge eating behaviour, we 
therefore recruited a heterogeneous sample of women who met criteria for either disorder. 
Twenty women met DSM-5 diagnostic criteria for BN, five women met DSM-5 diagnostic 
criteria for BED, and twenty-seven women had no prior history of an eating disorder at the 
time of the study. An a priori power analysis conducted in GPower indicated that a sample size 
of 20 participants per group would be sufficient to detect a mean difference between groups 
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with a medium effect size. Therefore, the sample size included in the study had more than the 
minimum number of participants indicated by the power analysis. The study was advertised on 
the website for a major eating disorder charity in the United Kingdom (Beat), via e-mail 
circulars at King’s College London, and on flyers displayed on community bulletin boards. 
The London – Camberwell St Giles NHS Research Committee granted ethical approval for the 
current study (reference: 14/LO/2115). All participants gave written informed consent in 
accordance with the Declaration of Helsinki. Full inclusion and exclusion criteria for the study 
are presented in the Supplementary Material. Eligibility for the current study was established 
via a phone screening, which included the Structured Clinical Interview for DSM-5 (Research 
Version) (25).  
Seven participants who met diagnostic criteria for BN or BED self-reported at least one 
comorbid psychiatric disorder. Specifically, 5 women had comorbid depression, 4 women had 
borderline personality disorder, 4 women had comorbid generalised anxiety disorder, 1 woman 
had obsessive-compulsive disorder, 1 woman had social anxiety, and 1 woman had an autism 
spectrum disorder. At the time of the study, 7 women were taking an antidepressant, 1 woman 
was taking an antipsychotic drug, and 1 woman was taking a mood stabiliser. Twenty-two of 
the fifty-two participants were taking hormonal contraception at the time of the study. Fifteen 
women completed the study whilst in the follicular phase of the oestrous cycle and thirteen 
women completed the study in the luteal phase of the menstrual cycle. There was not a 
significant difference between the BN/BED and healthy comparison participant groups in the 
distribution of women in the follicular phase, luteal phase, or on hormonal contraception, χ2 = 
4.61, df = 2, p = .100. Menstrual phase data were missing for two women. Descriptive statistics 
for the age, body mass index (BMI), and education level of the participant sample are presented 




This study used a double-blind placebo-controlled crossover design. Each participant 
came to the laboratory for three study visits: one orientation visit and two experimental 
sessions. During the orientation visit, each participant had the opportunity to discuss any 
queries with the researcher in person before signing informed consent and practising self-
administration of a placebo nasal spray. The height and weight of each participant was also 
measured during the orientation visit. At the conclusion of the orientation visit, each participant 
was provided with a link to an online survey, in which participants provided basic demographic 
data prior to the second study visit.  
 Each participant subsequently came to the laboratory for two experimental study visits. 
Participants received a divided dose of 64IU intranasal oxytocin (Synctocinon, 40IU/ml; 
Novartis, Basel, Switzerland) during one experimental study visit, and an equal volume of a 
placebo nasal spray (containing the same excipients as the oxytocin nasal spray but without the 
active ingredient of oxytocin) during the opposite visit. The order in which each participant 
received each nasal spray was pseudo-randomised, such that an equal number of participants 
received oxytocin on the first, versus the second, experimental study visit. Both the participant 
and the researcher were blind to the order in which each participant was allocated the oxytocin, 
versus placebo, nasal spray. These experimental study visits were held two days apart to ensure 
that each participant would complete both experimental study visits whilst in the same phase 
of the menstrual cycle. Perfusion data analysing the central effects of oxytocin suggest that 
carryover effects from oxytocin administration on the first experimental visit to the second 
experimental visit are highly unlikely (26). 
Participants were requested to abstain from consuming alcohol or caffeine from 8.00pm 
on the evening prior to each experimental study visit. Participants were also asked to eat 2.5 
hours prior to the beginning of each experimental study visit, and nothing else between this 
time and the beginning of the experimental study visit. 
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 Participants arrived for each study visit at 5.00pm. At 5.50pm, each participant self-
administered the first dose of the allocated nasal spray for that day: either 40IU oxytocin or an 
equal volume of the placebo nasal spray. Each participant then underwent a functional MRI 
scan, during which they viewed images of water and chocolate milk and received 0.5ml doses 
of water and chocolate milk via a tube. The results of this fMRI analysis are not reported in the 
current paper. We chose to administer a 40IU dose of oxytocin prior to the fMRI scan in order 
to replicate the previous Kim et al. (27) protocol, which found an effect of oxytocin on eating 
behaviour in women with BN at this dose. We additionally chose this dose as previous work 
has found that 40IU intranasal oxytocin effectively engages target regions associated with the 
neural processing of taste reward (26). 
The functional MRI scan ended at 7.00pm, 65 minutes after the completion of initial 
drug administration. Previous findings in humans have suggested that peak central effects of 
40IU intranasal oxytocin occur 39-51 minutes following administration (26), thus suggesting 
the need for an additional dose after this time. Therefore, at 7.10pm, participants self-
administered a second dose of the allocated nasal spray for that day: either 24IU oxytocin or 
an equal volume of the placebo nasal spray. At 7.25pm, each participant then completed a 
visual dot probe task, which is described in further detail below. Immediately following the 
completion of this task, each participant completed a “bogus” taste test, which is also described 
below. The taste test continued for a standard 15-minute duration. Following the taste test, each 
participant repeated the visual dot probe task. Subsequently, each participant reported whether 
they believed they had been allocated the oxytocin or placebo for that study visit. A timeline 
of the primary events which took place during each experimental visit is presented in Figure 
1. 
Visual Dot Probe Task 
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The visual dot probe task is a common test of attentional bias to disorder-relevant 
images, which has been used to measure attentional biases across a range of psychiatric 
disorders (28). The visual dot probe task used in the current study was adapted from Cardi and 
colleagues (29) and presented using E-prime software (Psychology Software Tools, 
Sharpsburg, USA). Each task run consisted of 96 trials. In each trial, the participant was first 
presented with two images side by side, with 115mm between the centre of each image. Each 
image belonged to one of two category types: food images (32 different images) or neutral 
images (48 different images). Food images depicted close-up photographs of palatable foods 
on a plate. Food was depicted in a “ready-to-eat” form without any packaging.  
Participants were presented with a total of 32 different food-neutral image pairs, and 
16 different neutral-neutral image pairs. Each image pair was presented twice (once with the 
food picture on the left, and once with the food picture on the right; the order of image pairings 
was randomly determined for each participant). All food images were matched for size and 
caloric content. Neutral images depicted furniture. Each image had a resolution of 72dpi, 
measured 45 x 70mm on the computer screen, and was matched for colour saturation. Each 
picture pair was presented for 500ms.  
Immediately following the presentation of each image pair, one of the images was 
replaced by a visual probe. Visual probes consisted of either a pair of horizontally or vertically 
oriented dots. Participants were instructed to press the letter ‘z’ as soon as they saw a pair of 
horizontally oriented dots, or the letter ‘q’ as soon as they saw a pair of vertically oriented dots. 
Stickers depicting the corresponding dot orientation were attached to the letters ‘q’ and ‘z’ on 
the keyboard to prevent confusion for participants. The inter-trial interval was 500ms. Reaction 
time and accuracy was recorded for each trial.  
Bogus Taste Test 
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The bogus taste test is a validated measure of eating behaviour used to test the effect of 
experimental factors on the consumption of palatable food (30). In the current study, each 
participant was presented with three types of food, each of which was contained in a 
standardised white ceramic bowl. One bowl contained 250g of grapes, one bowl contained 50g 
Walker’s ready-salted crisps, and the final bowl contained 220g Cadbury Bitsa Wispa 
chocolate. The bowls were presented in a standard order, with the bowl of grapes on being the 
leftmost bowl, followed by the bowl of crisps, and the bowl of chocolate being the rightmost 
bowl. Participants were asked to rate each type of food for tastiness, sweetness, saltiness, 
richness, and pleasantness on a visual analogue scale anchored from 0 to 10. As the researcher 
was leaving the room after explaining the instructions for the bogus taste test, the researcher 
told each participant as an “afterthought” that the participant was welcome to eat as much as 
they would like, as the remaining food would be thrown away. Participants were then left alone 
in a room with the three bowls of food for 15 minutes to complete the task. 
Following the completion of the bogus taste test, the three bowls of food were brought 
to a separate room, out of sight of the participant, where a research assistant weighed the 
remaining food in each bowl and subtracted this amount from the initial weight of each type of 
food. The effect of oxytocin on the quantity of food eaten is reported elsewhere (31). 
Statistical Analysis 
Attentional bias scores for each task run were calculated for the dot probe task by 
subtracting each participant’s mean reaction time to probes that were preceded by a food image 
from those that were preceded by a neutral image. Therefore, positive attentional bias scores 
indicate vigilance to food images, and negative attentional bias scores indicate avoidance of 
food images. Trials that presented matching image pairs (e.g., two neutral images) and trials in 
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which the participant responded incorrectly were excluded. All task runs for all participants 
met the minimum requirement of an 80% correct response rate. 
We tested our hypotheses using a 2 x 2 x 2 linear mixed effects model in the lmerTest 
package for R (32). We included experiment time point (before or after the taste test), eating 
disorder status (healthy controls or BN/BED), drug condition (placebo or oxytocin), and all 
associated interactions as fixed effects. The intercept for each participant was entered as a 
random effect. A preliminary linear mixed effects analysis was conducted to determine whether 
hormonal state (follicular phase, luteal phase, or current hormonal contraception) moderated 
the effect of oxytocin on attentional bias. The results of this linear mixed effects analysis are 
reported in Supplementary Table 1. The interaction effect between oxytocin and hormonal 
state was not significant, and hormonal state was therefore not included as a covariate in the 
final mixed effects model. We also conducted an additional linear mixed effects analysis to 
determine whether there was a significant effect of learning on attentional bias by comparing 
attentional bias between the participants’ first and second visits. There was not a significant 
simple main effect of visit number on attentional bias (estimate = -7.16, SE = 5.19, df = 141.98, 
t = -1.38, p = .170) nor was there a significant interaction between visit number and drug 
condition or visit number and eating disorder status on attentional bias. The full results of the 
interaction analysis are presented in Supplementary Table 2. 
Results 
 The attentional bias scores were first screened for outliers and violations of the 
assumption of normality. Four outliers (|Z| > 3.0) were found in the attentional bias variable 
and excluded from subsequent analyses. Three of these outlier data points were in the BN/BED 
participant group and one was in the healthy control participant group. Descriptive statistics 
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associated with the attentional bias scores are presented in Table 2 and visual depictions of the 
data are presented in Supplementary Figures 1 and 2. 
The linear mixed model found that none of the interaction effects reached significance 
in the full factorial model. The fixed effects associated with the full factorial linear mixed 
effects analysis are presented in Table 3. We did not identify any cases with excessive 
influence on the model (all Cook’s distances < 1.0). 
As there were not any significant interaction effects in the full factorial model, we 
therefore conducted a follow-up linear mixed effects analysis including only main effects. The 
main effects analysis revealed that neither eating disorder status nor experiment time point 
significantly affected attentional bias. However, there was a significant main effect of drug 
condition, such that oxytocin administration, versus placebo administration, was associated 
with significantly greater vigilance towards food images. The fixed effects associated with the 
linear mixed effects analysis are presented in Table 2. Again, we did not identify any cases 
with excessive influence on the model (all Cook’s distances < 1.0). 
Visual inspection of the data revealed a numerically greater difference in attentional 
bias to food images between the oxytocin and placebo conditions among participants with 
BED, as opposed to healthy control or BN participant groups. We therefore conducted a 
sensitivity analysis excluding BED participants. Given that this exclusion would substantially 
reduce power in light of an already low sample size, we imputed the mean for each drug 
condition and experiment time point among the BN participant group for an additional five 
simulated BN participants.  After excluding participants with BED, the effect of drug condition 
was no longer significant (p = .084) although there was a trend towards an effect in the same 
direction. Full results of this sensitivity analysis are reported in Supplementary Table 3. 
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Finally, given that we hypothesised that we would observe group differences in the 
effect of oxytocin on attentional biases driven by a flooring effect in the healthy control group, 
even in the absence of these group differences, we were interested to explore whether baseline 
attentional bias to food stimuli in the placebo condition was associated with the degree of 
change induced by oxytocin administration. The attentional bias variable in the placebo 
condition and the attentional bias difference variable were approximately normally distributed 
at both Time Point 1 and Time Point 2 (skew < 2.0 and kurtosis < 2.0 for all variables). We 
therefore deemed it appropriate to conduct a Pearson’s correlation test. This correlation 
analysis revealed that greater avoidance of food images in the placebo condition was associated 
with a greater increase in attentional bias induced by oxytocin at both Time Point 1 (r = 0.70, 
N = 49, p < .001 ) and Time Point 2 (r = 0.65, N = 47, p < .001 ) within each experimental visit. 
The scatter plots associated with the correlation analyses for Time Point 1 and Time Point 2 
are presented in Supplementary Figure 3 and Supplementary Figure 4. We also conducted 
an exploratory linear mixed effects analysis investigating whether the number of calories 
consumed in the taste test impacted attentional bias or the effect of oxytocin on attentional bias. 
This linear mixed effects analysis did not reveal any significant main or interaction effects with 
experiment time point or drug condition. The full results of this analysis are reported in 
Supplementary Table 4. 
Discussion 
 The current study aimed to test the effect of a divided dose of 64IU intranasal oxytocin 
on attentional bias to food images in women with and without BN or BED. We hypothesised 
that women with BN or BED would demonstrate greater vigilance towards food images and 
that oxytocin administration would reduce vigilance towards food images in both participant 
groups, but with a stronger effect in the BN/BED versus healthy comparison group. 
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 Our first hypothesis was not supported by the results, as there was no main effect of 
eating disorder status on attentional bias to food images. Oxytocin was found to have a 
significant effect on attentional bias; however, this was in the opposite direction to our 
hypothesis. That is, oxytocin was found to increase vigilance to food images; however, this 
effect was moderated by baseline attentional biases, such that greater avoidance of food stimuli 
in the placebo condition was associated with greater increases in vigilance induced by oxytocin. 
The main effect of oxytocin, associated with an increase in vigilance to food images, was 
primarily driven by the five participants with BED, as the significance of this effect did not 
survive after excluding participants with BED. Our third hypothesis was also not supported by 
the results as there was not a significant interaction between oxytocin treatment and eating 
disorder status on attentional bias to palatable food. Finally, we did not find evidence of an 
interaction between participant group and time point (before or after the taste test) on 
attentional bias to food images.   
The lack of difference in baseline attentional bias to food stimuli between women with, 
versus without, BN or BED is in contrast to previous studies using Stroop tasks (3). This 
contrast in findings may be due, in part, to differences in the food-related stimuli presented: 
food images being used in the current study versus food words in the Stroop task. However, 
previous evidence has suggested that food images are rather associated with a greater 
difference in attentional bias to food amongst participants with eating disorders and healthy 
controls, when compared to word stimuli (33). The null effect of eating disorder status in the 
current study may, therefore, rather be due to the stage of attention processing targeted in the 
current study. The target for the task was presented 500ms after each image pair, while the 
nature of the Stroop task necessarily requires that the target be presented simultaneously with 
the food-related word. This is potentially relevant given previous eye-tracking evidence finding 
no difference in attention to food images among women with anorexia nervosa at early stages 
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of attentional processing but avoidance of food images at later stages of attentional processing 
(18). If similar variation in attentional biases also exist in populations with BN and BED, it is 
possible that the current study failed to detect differences in attentional bias before or after the 
target appeared.  
The finding that oxytocin induced greater, rather than less, vigilance towards food 
stimuli in the current study was surprising, and contrasted with our hypothesis that oxytocin 
would reduce vigilance to food stimuli across all study participants. However, it should be 
noted that the increased vigilance observed in the current study was not robust to the exclusion 
of the five participants with BED, even after imputing the mean for five simulated participants 
with BN to make up for the loss of power.  Although the sample of participants with BED was 
not large enough to warrant a moderation analysis comparing the influence of oxytocin on 
participants with BN versus BED, these preliminary results demonstrating numerical 
divergence in the effect of oxytocin on attentional bias to palatable food among each disorder 
suggest that attentional biases to palatable food should be investigated separately among 
samples with BN and BED in future studies. On the whole, given that baseline attentional 
biases in women with anorexia nervosa have previously been found to be away from food 
images (17), rather than towards food images, the evidence to date suggests that, on average, 
oxytocin increases vigilance to food images in women, with correlation analyses suggesting 
that this effect is greater in participants with baseline attentional avoidance of food stimuli. 
The mechanism by which oxytocin increases attentional bias to food images in women 
is yet unclear, but may involve interactions with dopaminergic signalling systems in 
mesolimbic brain regions (34). Specifically, binding to oxytocin receptors in the ventral 
tegmental area and nucleus accumbens, two regions strongly related to reward processing, may 
initiate neural processes ultimately enhancing reward salience of signals (including food) in 
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the immediate environment (35). However, it should be noted that this hypothesis is still in the 
speculative stage of proposal and requires additional empirical evidence for corroboration. 
The hypothesis that binge eating is partially driven by heightened reward salience, in 
combination with the finding that oxytocin increases vigilance to food stimuli, is difficult to 
consolidate with previous findings demonstrating that oxytocin decreases hedonic food 
consumption (24). That is, one might reasonably hypothesise that reduced hedonic food 
consumption would be associated with less attentional and motivational orientation to food 
stimuli. However, previous studies finding a suppression of hedonic eating reported this effect 
in male participant samples (20, 24, 36), while no effect of oxytocin on feeding was found in 
the current sample of female participants (31). An accumulating range of studies has found 
mixed effects of oxytocin on eating in women, both with and without eating disorders (17, 27), 
therefore suggesting that the inhibitory effect of oxytocin on hedonic eating and orienting to 
food stimuli may be sex-specific in humans. However, further research is necessary to clarify 
whether oxytocin may influence reward salience attribution and actual food consumption via 
different mechanisms. 
There is evidence to suggest that the potency of oxytocin on psychosocial functioning 
has an inverse quadratic function with drug dose (37). Given the relatively high dose of 
oxytocin administered in the current study (a divided dose of 64IU), it may therefore be the 
case that oxytocin administration does have different effects on attentional bias in this 
population at lower doses. Previous evidence has indicated that the effects of oxytocin on 
resting neural activation vary over time (38). Therefore, it is possible that the functional effects 
of oxytocin on attentional biases to palatable food may also differ at other time points after 
administration given differing bioavailability of exogenous oxytocin to neural regions 
underpinning the control of attentional bias. 
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 Additional limitations of the current study include the low sample size and our inability 
to measure the effects of oxytocin on early and late stages of attentional processing due to the 
nature of the dot probe task. It should be noted that a different pattern of effects may be found 
at different points within the time course of attentional processing given that different patterns 
of attentional vigilance, versus avoidance, have been observed at different stages of attentional 
processing in other eating disorders (18). Future studies of attention bias in BN and BED may 
be improved through the use of alternative measures of attentional bias, such as eye-tracking 
tasks. Additionally, as oxytocin has been found to have sex-specific effects in other studies of 
psychopathology (39), the current findings should therefore not be generalised to men with BN 
and BED.   
 Finally, while we recruited women with BN and BED within our clinical sample in the 
current study, given that the primary trait of interest, recurrent loss-of-control binge eating 
behaviour, occurs in both disorders, it is worth noting that populations with BN versus BED 
differ in important ways. For example, people with BN are more likely to have a prior history 
of anorexia nervosa (40), while people with BED are more likely to be overweight or obese 
(41). Additionally, there is a greater degree of evidence to support elevated risk of obsessive-
compulsive behaviours and borderline personality disorder in BN, compared to BED (42, 43). 
Therefore, these differences in aetiology and clinical profile, in combination with the 
divergence in the effects of oxytocin observed in the current study, suggest that it would be 
preferable to research populations with BN and BED separately in future. 
 In conclusion, this is the first study to our knowledge to investigate the influence of 
oxytocin on attentional bias to food images in women with BN and BED and healthy 
comparison women. A divided dose of 64IU intranasal oxytocin increased vigilance to 
palatable food images, although this effect is moderated by baseline attentional bias toward 
food images in the placebo condition. Further studies testing the effects of oxytocin on 
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attentional biases to palatable food at different doses and time courses of administration in 






Descriptive demographic data 
 Healthy Control (n = 27) BN/BED (n = 25) 
 Median IQR Median IQR 
Age 23.50 5.50 23.50 9.75 
BMI 22.04 1.76 23.09 3.87 
RQF Education Level 6 4 4.5 3 
Note. BN = bulimia nervosa; BED = binge eating disorder; IQR = interquartile range; BMI = 






Results of the linear mixed effects analysis testing the main effects of eating disorder status, 
oxytocin, and food presentation (experiment time point) on attentional bias to food images 
 
 HC (n = 27) 
Mean(SD) 







Oxytocin 10.07(37.200) 10.54(39.720) ED Status: Z = 5.70, SE = 
6.206, df = 46.00, p = .363 
Drug Condition: Z = 10.42*, 
SE = 5.136, df = 142.20, p = 
.044 
Experiment Time Point: Z = 
1.10, SE = 5.14, df = 143.76, 
p = .831 




Oxytocin 2.74(31.922) 19.93(42.467) 
Placebo -0.26(26.770) 2.29(36.677) 
    Random 
Effects 
Variance 
    Individual 
Participant 
151 
    Residuals 1284 
Note. BED = Binge eating disorder; BN = Bulimia nervosa; ED = Eating disorder; HC = Healthy 
control. 




Results of the linear mixed effects analysis testing a full factorial model with fixed effects for eating 
disorder status, oxytocin, and food presentation (experiment time point) on attentional bias to food 
images 
Fixed Effects Estimate SE df t p 
Intercept -0.45 16.170 163.81 -0.03 .978 
ED Status -1.75 22.868 163.86 -0.08 .939 
Drug Condition 17.85 22.536 141.17 0.79 .430 
Experiment Time Point -0.08 10.169 142.17 -0.01 .994 
ED Status * Drug Condition -14.80 32.083 141.71 -0.46 .645 
ED Status * Experiment Time Point 2.68 14.382 142.30 0.19 .853 
Drug Condition * Experiment Time 
Point 
-7.25 14.301 141.55 -0.51 .613 
ED Status * Drug Condition * 
Experiment Time Point 
14.62 20.390 141.91 0.72 .475 
Random Effects Variance     
Individual Participant 159.8     
Residuals 1263.9     
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